ARTICLE | Company News
Debiopharm ventures into antibiotics with TCG deal
September 10, 2013 12:28 AM UTC
Debiopharm Group (Lausanne, Switzerland) partnered with contract research services company TCG Lifesciences Ltd. (Kolkata, India) to exclusively discover and develop an undisclosed class of antibiotics against drug-resistant bacteria for hospital-acquired (nosocomial) infections. Debiopharm has already licensed the first compound from TCG, Debio 1348, which is in discovery. The partners could not be reached for details. ...